Clinical Intelligence

Hitting For Power

Tuesday, December 19, 2006

There’s been so much written about Pfizer’s failure to get torcetrapib through clinical trials and big pharma’s outdated blockbuster mentality that it’s easy to overlook that pharma is finally making some progress in reducing the huge cost of drug development. And that sometimes going for the home run makes sense.

[Read More]

Top Stories for the Week of Dec. 11th, 2006

Tuesday, December 12, 2006

Top News

Bridgetech Opens New Clinical Research Site in Hong Kong

Bridgetech Holdings International, along with The Chinese University of Hong Kong (CUHK), has opened a new oncology-focused clinical trial site in Hong Kong.

eStudySite Raises $6 Million to Expand with Additional Centers

San Diego, Calif.-based clinical trial management company eStudySite raised $6 million in its first round of institutional financing.

Other breaking news…

[Read More]

Top Stories for the Week of Dec. 4th, 2006

Tuesday, December 5, 2006

Top News



AstraZeneca to Use Medidata’s eClinical Solutions for All Clinical Trials

The New York, N.Y.-based eClinical company Medidata Solutions has been awarded a major contract from AstraZeneca to provide the company with its Medidata Rave electronic data capture (EDC), replacing AstraZeneca’s present in-house system.

Covance Opens New Phase I Facility in Hawaii

Expanding to meet a growing demand to conduct special trials in specific ethnic patient populations, New Jersey-based contract research organization Covance has opened a new clinical research facility in Honolulu.

Other breaking news…

[Read More]

FDA Proposes New Regulations for Expanded Access to Investigative Drugs

Tuesday, November 21, 2006

The U.S. Food and Drug Administration (FDA) has submitted two regulatory proposals that would expand the rules concerning who has access to investigative treatments. The new proposals would provide a clearer pathway for certain critically ill patients so they can be considered for access to investigative drugs without enrolling in a clinical trial.Both proposals have been submitted to the Office of Management and Budget (OMB), where they will be reviewed for approval.

[Read More]